Method for detecting hepatitis B virus DNA and G1896A mutation thereof and kit
A hepatitis B virus, G1896A technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve problems such as prolonging the running time of PCR programs, achieve beautiful and stable amplification curves, reduce detection costs, and facilitate The effect of promoting the application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0098] Example 1: Extraction of HBV DNA from clinical blood samples
[0099] Take 50μl of serum from clinical blood samples into a high-pressure 1.5ml centrifuge tube, add 25μl of extract A (40% PEG-8000), shake and mix for 5s, and centrifuge at 12,500g for 5min; discard the supernatant, add 25μl to extract Solution B (0.25M NaOH), shake for 15s to dissolve the precipitate as much as possible, lyse at 96°C for 10min; add 25μl of extract C (0.4M Tris-HCl buffer, pH6.4), mix well, 96°C for 10min; centrifuge at 12,500g After 15 min, 5 μl of supernatant was taken for PCR amplification.
Embodiment 2
[0100] Example 2: PCR Amplification of Target Nucleic Acids
[0101] Add a single dose of PCR reaction mixture to a PCR reaction tube, then add 0.2 μl of enzyme mixture, and finally add 5 μl of template (template to be tested or negative and positive control), mix well and then centrifuge slightly (about 5 μl). second). Then put the reaction tube into a fluorescent PCR machine (a PCR machine that can detect FAM and HEX), and amplify according to the following conditions: 50°C for 120 seconds (1 cycle) → 95°C for 180 seconds (1 cycle) → 95°C for 10 seconds seconds, 56°C for 30 seconds (40 cycles), where 56°C is the temperature at which fluorescence is detected.
[0102] The PCR amplification system used includes: 2.5μl 10x PCR buffer (850mM KCl, 400mM Tris-Cl, pH8.9, 50% v / v glycerol), 0.2μl enzyme mixture, 0.2μl dUTPs (containing dATP, dUTP, dGTP, dCTP each 25mM), two forward and reverse primers (SEQ ID NO: 1 and SEQ ID NO: 2, 100 μM) each 0.1 μl, wild type and mutant molecu...
Embodiment 3
[0103] Example 3: Hepatitis B virus DNA G 1896 Sensitive and specific detection of A mutation
[0104] with G 1896 A plasmid of mutated hepatitis B virus DNA fragment (1.0 × 10 6 copies / ml-1.0×10 2 copies / ml) as a template, use the reagent of the present invention to treat hepatitis B disease
[0105] Toxic DNA G 1896 The sensitivity of A mutation is detected. For the detection results, see figure 1 . from figure 1 It can be seen from the results that the method and kit of the present invention can at least detect that the template concentration is only 1.0×10 2 copies / ml G 1896 A mutated hepatitis B virus DNA. In other words, the sensitivity of the present invention can fully meet the clinical requirements.
[0106] Then 16 wild-type hepatitis B virus DNA (about 1.0 × 10) with no mutation at site 1896 6 copies / ml) is a template, and the specificity of the mutant probe marked by FAM is detected using the reagent of the present invention, and the detection results re...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com